Founded in 2000, Strategy Inc. provides high-level business due diligence and valuation consulting services to the global medical device community. Our diverse client base includes venture capital companies, emerging technology companies, law firms specializing in emerging biomedical technology, multinational medical device companies, philanthropic biomedical foundations and others located in the US, France, Spain, Israel and other countries across the globe.
Strategy Inc. offers the following services customized to client needs:
Business plan development
Market due diligence
Valuation for acquisition, merger or licensing
Facilitation of funding and technology acquisition/licensing
Prioritization among technologies for those with the highest probability for
successful commercialization
Platform analysis for expanded indications
Exit strategy identification and implementation
Competitive analysis
Investor Package
Clinical adoption projections
Strategy Inc. is managed by two seasoned healthcare executives with a proven track record of success and over 35 years of combined experience in the medical device industry. In addition, our team of consultants includes a committed group of medical device marketing and business development experts who have been working together for nearly 10 years. Each consultant has a rich depth of experience in business analysis and company valuation, as well as technology and clinical assessment within the medical device industry.
Our team has proven expertise in many clinical areas including neurostimulation, cardiovascular medicine, oncology, orthopedics, gastroenterology, transplantation, dermatology, wound closure, surgical infection prevention, women's health, men's health, energy-based therapeutics and diagnostics and many others.
